GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Wuhan YZY Biopharma Co Ltd (HKSE:02496) » Definitions » PB Ratio

Wuhan YZY Biopharma Co (HKSE:02496) PB Ratio : 10.35 (As of Jun. 05, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Wuhan YZY Biopharma Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-05), Wuhan YZY Biopharma Co's share price is HK$7.45. Wuhan YZY Biopharma Co's Book Value per Share for the quarter that ended in Dec. 2023 was HK$0.72. Hence, Wuhan YZY Biopharma Co's PB Ratio of today is 10.35.

The historical rank and industry rank for Wuhan YZY Biopharma Co's PB Ratio or its related term are showing as below:

HKSE:02496' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 33.92
Current: 10.35

During the past 3 years, Wuhan YZY Biopharma Co's highest PB Ratio was 33.92. The lowest was 0.00. And the median was 0.00.

HKSE:02496's PB Ratio is ranked worse than
90.46% of 1310 companies
in the Biotechnology industry
Industry Median: 2.535 vs HKSE:02496: 10.35

During the past 12 months, Wuhan YZY Biopharma Co's average Book Value Per Share Growth Rate was -20.20% per year.

Back to Basics: PB Ratio


Wuhan YZY Biopharma Co PB Ratio Historical Data

The historical data trend for Wuhan YZY Biopharma Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan YZY Biopharma Co PB Ratio Chart

Wuhan YZY Biopharma Co Annual Data
Trend Dec21 Dec22 Dec23
PB Ratio
- - 12.36

Wuhan YZY Biopharma Co Semi-Annual Data
Dec21 Dec22 Dec23
PB Ratio - - 12.36

Competitive Comparison of Wuhan YZY Biopharma Co's PB Ratio

For the Biotechnology subindustry, Wuhan YZY Biopharma Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuhan YZY Biopharma Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Wuhan YZY Biopharma Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Wuhan YZY Biopharma Co's PB Ratio falls into.



Wuhan YZY Biopharma Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Wuhan YZY Biopharma Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=7.45/0.72
=10.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Wuhan YZY Biopharma Co  (HKSE:02496) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Wuhan YZY Biopharma Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Wuhan YZY Biopharma Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan YZY Biopharma Co (HKSE:02496) Business Description

Traded in Other Exchanges
N/A
Address
No. 666 Gaoxin Road, East Lake High Tech, Development Zone, Hubei Province, Wuhan, CHN
Wuhan YZY Biopharma Co Ltd is a biotechnology company specifically involved in developing bispecific antibody based therapies to treat cancer or cancer-associated complications, cancer and age-related ophthalmologic diseases to address medical demands in oncology and aging-related ophthalmologic disease areas, The Company has been operating in one reportable segment, being the discovering, developing and commercializing new class of innovative medicines in respect to anti-tumor bispecific antibody.
Executives
Dragon Merit Holdings Limited 2201 Interest of corporation controlled by you
Robust Sun Holdings Limited 2201 Interest of corporation controlled by you
Cspc Pharmaceutical Group Limited 2201 Interest of corporation controlled by you
Shi Yao Ji Tuan En Bi Pu Yao Ye You Xian Gong Si 2101 Beneficial owner
He Bei Yi Er Qi Ye Guan Li Zi Xun You Xian Gong Si 2201 Interest of corporation controlled by you
Ning Bo Mei Shan Bao Shui Gang Qu Guang Rui Hong Xiang Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Guo Xin Si Chuang Tou Zi Ji Jin Guan Li Bei Jing You Xian Gong Si 2201 Interest of corporation controlled by you
Guo Hong Wei
Nan Jing Cai Zhi Er Hao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Nan Ning Hui You Xing Yao Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo
Nan Ning Yao You Shang Wu Zi Xun He Huo Qi Ye You Xian He Huo
Wen Zhi Cheng
Tong De Qian Yuan Bei Jing Tou Zi Guan Li You Xian Gong Si
Wang Hongjie 2201 Interest of corporation controlled by you
Wu Shangzhi 2201 Interest of corporation controlled by you

Wuhan YZY Biopharma Co (HKSE:02496) Headlines

No Headlines